摘要
目的讨论静脉溶栓后尤瑞克林联合依达拉奉治疗急性脑梗死的临床效果。方法选取2015年8月—2016年12月我院收治的急性脑梗死患者78例作为研究对象,将其随机分成实验组(39例)和对照组(39例)。实验组患者在静脉溶栓治疗后给予尤瑞克林和依达拉奉进行治疗,对照组在静脉溶栓治疗后给予依达拉奉进行治疗,对两组患者的治疗效果进行对比和分析。结果实验组的治疗有效率高于对照组,差异具有统计学意义(P<0.05);实验组患者的日常生活活动能力评分高于对照组,差异具有统计学意义(P<0.05)。结论静脉溶栓后尤瑞克林联合依达拉奉治疗急性脑梗死的临床效果明确。
Objective To discuss the clinical effect of intravenous urinary kallidinogenase combined with edaravone in the treatment of acute cerebral infarction. Methods 78 patients with acute cerebral infarction treated in our hospital from August 2015 to December 2016 were selected and randomly divided into the experimental group （39 cases） and the control group （39 cases）. In the experimental group were given intravenous thrombolytic therapy after urinary kallidinogenase and edaravone treatment in the control group after intravenous thrombolytic therapy of edaravone for treatment, comparison and analysis of the effect of two groups of patients. Results The treatment efficiency of the experimental group was higher than that of the control group, the difference was statistically significant （P 〈 0.05）; The scores of activities of daily living in the experimental group were higher than those in the control group, the difference was statistically significant （P 〈 0.05）. Conclusion The clinical effect of intravenous Yuri thrombolysis combined with edaravone in the treatment of acute cerebral infarction is clear.
作者
刘美玲
LIU Meiling(Neurology Department, Songyuan Center Hospital, Songyuan Jilin 138000, China)
出处
《中国继续医学教育》
2017年第23期153-155,共3页
China Continuing Medical Education
关键词
静脉溶栓
尤瑞克林
依达拉奉
急性脑梗死
intravenous thrombolysis
urinary kallidinogenase
edaravone
acute cerebral infarction
